Future prospect of polysaccharide as a potential therapy in hepatocellular carcinoma: A review

Yue Cai,Jing Guo,Yongbo Kang
DOI: https://doi.org/10.1016/j.ijbiomac.2024.132300
IF: 8.2
2024-05-19
International Journal of Biological Macromolecules
Abstract:Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. HCC almost exclusively develops in patients with chronic liver disease, driven by a vicious cycle of liver injury, inflammation and regeneration that typically spans decades. A variety of new agents are in development for the treatment of the disease. Polysaccharide is important component of higher plants, membrane of the animal cell and the cell wall of microbes. It is also closely related to the physiological functions. Recently, there has been growing interest in polysaccharides as bioactive natural products, particularly in treating HCC. This paper provides a review of recent experimental and clinical studies on the effects and potential applications of polysaccharides in HCC treatment, aiming to offer theoretical insights and inspiration for further research on the bioactivity mechanisms of polysaccharides in HCC treatment.
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?